Piao S, Zhao S, Guo F, et al. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. J Cancer Res Clin Oncol 2012; 138(4): 627–635.
de Vicente JC, Lequerica-Fernández P, López-Arranz JS, et al. Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential. Laryngoscope 2008; 118(2): 247–251.
Chen Y, Tian K, Geng N, et al. The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma.Zhonghua Kou Qiang Yi Xue Za Zhi 2005; 40(1): 58–61.
Luukkaa H, Klemi P, Leivo I, et al. Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER -2 in epithelial-myoepithelial salivary gland cancer. Head Neck 2010; 32(8): 1019–1027.
Nagel H, Laskawi R, W ahlers A, et al. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TI MP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology 2004; 44(3): 222–231.
Ignatowicz A, Kornafel J. Epidemiologia nowotworów złośliwych wczoraj i dziś. Prim Care Rev 2008; 10(3): 848–852.
Hudziec P, Kornafel J. Łacko A. Choroby nowotworowe – czy będą epidemią XXI wieku. Fam Med Prim Care Rev 2005; 7(2):279–282